Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlanbia Regulatory News (GLB)

Share Price Information for Glanbia (GLB)

Share Price is delayed by 15 minutes
Get Live Data
21.00    -1.00 (-4.55%)
Bid:
20.00
Ask:
22.00
Spread: 2.00 (10.00%)
Market Cap: €5.08b
GLB Live PriceLast checked at - London Stock Exchange

Intraday Glanbia Share Chart

Transaction in Own Shares

20 Jan 2022 12:11

RNS Number : 1288Z
Glanbia PLC
20 January 2022
 

Glanbia plc Transaction in Own Shares

 

20 January 2022, Glanbia plc ("Glanbia" or "the Company"), the global nutrition Company has been informed that Glanbia Co-operative Society ("the Co-op") has completed the sale of approximately 5.75 million ordinary shares in the Company (the "Shares"), representing around 2 percent of the Company's issued share capital, for a total consideration of approximately €70 million (the "Equity Placement"). Concurrently with the Equity Placement, the Co-op placed EUR 250 million senior secured bonds and certain subscribers to these bonds placed existing Shares (the "Delta Shares") together with the Equity Placement (the "Placement")

The price per Share in the Placement was €12.25 and was determined by a book-build offering to institutional investors with settlement expected to occur on or around 24 January 2022.

Pursuant to the Company's existing authority to repurchase shares, the Company has participated in the Placement via Glanbia's broker Davy and today purchased 2,527,152 Shares (representing around 0.9 percent of the Company's existing issued share capital), at a price of €12.25 per Share (the "Buyback"). The Shares purchased in the Buyback will be cancelled. Following settlement of the above transaction and subsequent share cancellation Glanbia will have 284,022,805 ordinary shares in issue.

The purchase of shares from the Co-op as part of the Buyback constitutes a related party transaction for the Company under the Euronext Listing Rules ("Euronext LR") and the FCA Listing Rules ("FCA LR"). Pursuant to paragraph 11.1.15 (2)(a) of the Euronext LR and paragraph 11.1.10 (2)(b) of the FCA LR, Davy Corporate Finance confirms that the terms of the Buyback with the related party, are fair and reasonable as far as the shareholders of the Company are concerned.

The Buyback completed today by the Company is incremental to the ongoing €50 million share repurchase programme announced on 8 December 2021.

ENDS

For further information please contact:

Glanbia plc +353 56 777 2200

Mark Garvey, Group Finance Director

Liam Hennigan, Group Director of Strategic Planning & Investor Relations: +353 86 046 8375

Martha Kavanagh, Head of Corporate Communications: +353 87 646 2006

 

Davy +353 1 679 7788

Ivan Murphy/Ronan Veale

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBDGDBIGDDGDG
Date   Source Headline
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 202611:31 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20262:53 pmRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20261:26 pmRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 202612:06 pmRNSPublication of Notice of AGM & Proxy Voting Form
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20261:53 pmRNSAnnual Financial Report
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 202611:58 amRNSDirector/PDMR Shareholding
2nd Mar 20268:44 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSDividend Payment Date
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:30 amRNSGlanbia launches share buyback
25th Feb 20267:00 amRNSGlanbia Full Year 2025 Results
16th Dec 20252:08 pmRNSPublication of AGM Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.